eBangor

Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis

Dimitroulas, T. and Sandoo, A. and Smith, J.P. and Kitas, G.D. (2014) Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis. International Journal of Cardiology, 172 ((1)). pp. 285-286. DOI: 10.1016/j.ijcard.2013.12.235

Full-text not available from this repository..

Abstract

Rheumatoid Arthritis (RA) is associated with increased cardiovascular (CV) mortality and reduced life expectancy predominantly due to increased rates of acute coronary syndromes including unrecognized myocardial infractions [1]. The increased CV burden in this population has prompted rheumatologists and cardiologists to a more early and vigilant screening for CV risk stratification even in asymptomatic patients. Asymmetric dimethylarginine (ADMA) and subendocardial viability ratio (SEVR) represent non-invasive methods of assessing endothelial dysfunction and coronary microvascular perfusion to subendocardium respectively, two pivotal players in the development of CV disease and myocardial ischemia

Item Type: Article
Subjects: Research Publications
Departments: College of Health and Behavioural Sciences > School of Sport, Health and Exercise Sciences
Date Deposited: 13 Dec 2014 03:47
Last Modified: 23 Sep 2015 03:00
ISSN: 0167-5273
URI: http://e.bangor.ac.uk/id/eprint/3285
Identification Number: DOI: 10.1016/j.ijcard.2013.12.235
Publisher: Elsevier
Administer Item Administer Item

eBangor is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.